Ameriprise’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$495K Buy
64,523
+26,731
+71% +$183K ﹤0.01% 3589
2025
Q4
$74.8K Buy
37,792
+6,495
+21% +$14.7K ﹤0.01% 4023
2025
Q3
$77K Buy
31,297
+1,267
+4% +$3.26K ﹤0.01% 3992
2025
Q2
$79.3K Sell
30,030
-8,774
-23% -$23.6K ﹤0.01% 3898
2025
Q1
$117K Buy
38,804
+23,790
+158% +$72.1K ﹤0.01% 3862
2024
Q4
$38.4K Buy
+15,014
New +$62.5K ﹤0.01% 4021
2024
Q3
Sell
-11,155
Closed -$70.5K 3972
2024
Q2
$70.5K Sell
11,155
-3,860
-26% -$25.4K ﹤0.01% 3802
2024
Q1
$80.6K Sell
15,015
-6,085
-29% -$27.6K ﹤0.01% 3792
2023
Q4
$106K Buy
+21,100
New +$66.2K ﹤0.01% 3808
2023
Q3
Sell
-22,400
Closed -$62.3K 3919
2023
Q2
$62.3K Buy
+22,400
New +$63.3K ﹤0.01% 3855
2023
Q1
Sell
-67,995
Closed -$345K 3984
2022
Q4
$345K Buy
+67,995
New +$373K ﹤0.01% 3537
2021
Q4
Sell
-27,615
Closed -$269K 4005
2021
Q3
$269K Sell
27,615
-520
-2% -$5.72K ﹤0.01% 3618
2021
Q2
$402K Buy
28,135
+35
+0.1% +$578 ﹤0.01% 3536
2021
Q1
$667K Buy
28,100
+490
+2% +$12.7K ﹤0.01% 3302
2020
Q4
$368K Buy
+27,610
New +$266K ﹤0.01% 3438
2018
Q4
Sell
-11,850
Closed -$44K 3703
2018
Q3
$44K Buy
11,850
+240
+2% +$759 ﹤0.01% 3668
2018
Q2
$35K Buy
+11,610
New +$43K ﹤0.01% 3609

Other funds holding IBRX